Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

14.67
-0.6900-4.49%
Post-market: 14.40-0.2655-1.81%19:59 EDT
Volume:13.34M
Turnover:195.74M
Market Cap:16.81B
PE:-10.12
High:15.09
Open:15.08
Low:14.45
Close:15.36
Loading ...

Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth

THOMSON REUTERS
·
29 Jan

Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth

GlobeNewswire
·
29 Jan

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
29 Jan

Teva Pharmaceutical Industries Ltd expected to post earnings of 70 cents a share - Earnings Preview

Reuters
·
27 Jan

Alvotech, Teva Filing for Inflammatory Treatment Candidate Accepted for FDA Review

MT Newswires Live
·
27 Jan

Alvotech, Teva announce FDA accepts BLA for AVT05

TIPRANKS
·
27 Jan

Alvotech Sa - FDA Review Process Expected to Complete in Q4 2025

THOMSON REUTERS
·
27 Jan

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for Avt05, a Proposed Biosimilar to Simponi® and Simponi Aria® (Golimumab)

THOMSON REUTERS
·
27 Jan

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

GlobeNewswire
·
27 Jan

FDA adds boxed warning to Teva’s Copaxone for allergic reaction

TIPRANKS
·
23 Jan

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

TipRanks
·
18 Jan

Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations

Benzinga
·
18 Jan

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

Yahoo Finance
·
17 Jan

Teva price target raised to $30 from $23 at Piper Sandler

TIPRANKS
·
17 Jan

Teva Pharmaceutical (TEVA) Receives a Buy from Piper Sandler

TIPRANKS
·
17 Jan

Barclays Remains a Buy on Teva Pharmaceutical (TEVA)

TIPRANKS
·
17 Jan